Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Mihai-Vasile Marinca"'
Autor:
Eliza-Maria Froicu, Oriana-Maria Oniciuc, Vlad-Adrian Afrăsânie, Mihai-Vasile Marinca, Silvia Riondino, Elena Adriana Dumitrescu, Teodora Alexa-Stratulat, Iulian Radu, Lucian Miron, Gema Bacoanu, Vladimir Poroch, Bogdan Gafton
Publikováno v:
Diagnostics, Vol 14, Iss 18, p 2074 (2024)
Background: Machine learning models learn about general behavior from data by finding the relationships between features. Our purpose was to develop a predictive model to identify and predict which subset of colorectal cancer patients are more likely
Externí odkaz:
https://doaj.org/article/bfdcaefacaa849c08bfba0c900e5a35c
Autor:
Diana Cornelia Moisuc, Mihai Vasile Marinca, Bogdan Gafton, Teodora Alexa-Stratulat, Mariana Pavel-Tanasa, Petru Cianga
Publikováno v:
Current Oncology, Vol 29, Iss 6, Pp 3996-4011 (2022)
Treatment with bevacizumab is known to cause adverse events such as proteinuria and hypertension, amongst others. However, while bevacizumab-induced hypertension has been linked to increased overall survival (OS), data on proteinuria are controversia
Externí odkaz:
https://doaj.org/article/4d79541a3cd94ae5bdfaf4367810b88b
Autor:
Ludmila Lozneanu, Irina-Draga Caruntu, Cornelia Amalinei, Mihaela Moscalu, Bogdan Gafton, Mihai Vasile Marinca, Andreea Rusu, Raluca Balan, Simona-Eliza Giusca
Publikováno v:
Folia Histochemica et Cytobiologica. 61:1-16
Autor:
Sabina A Antoniu, Ioana Dana Alexa, Teodora Alexa, Bogdan Gafton, Mihai Vasile Marinca, Ramona Stefaniu, Adina Carmen Ilie
Publikováno v:
Expert Review of Anticancer Therapy. 21:315-323
Introduction: In the elderly non-small cell lung cancer (NSCLC) is more commonly diagnosed in advanced stages. Conservative therapy including chemotherapy in this age group might be challenging bec...
Autor:
Vlad-Adrian Afrăsânie, Teodora Alexa-Stratulat, Adina-Emilia Croitoru, Cristina Rusu, Gheorghe G. Balan, Anca-Viorica Ivanov, Lucian Miron, Bogdan Gafton, Mihai Vasile Marinca
Publikováno v:
Journal of Gastrointestinal and Liver Diseases. 29:251-256
Background and Aims: The coexistence of RAS and BRAF mutations is extremely rare, occurring in approximately 0.05% of patients with metastatic colorectal cancer (mCRC). Starting from a case presentation, this review aims to examine the prevalence, cl
Autor:
Gabriela Bordeianu, Nina Filip, Andrei Cernomaz, Bogdan Veliceasa, Loredana Liliana Hurjui, Alin Constantin Pinzariu, Mihaela Pertea, Andreea Clim, Mihai Vasile Marinca, Ionela Lacramioara Serban
Publikováno v:
Biomedicines. 11:705
Lung cancer remains a major public health problem both in terms of incidence and specific mortality despite recent developments in terms of prevention, such as smoking reduction policies and clinical management advances. Better lung cancer prognosis
Autor:
Vlad-Adrian Afrăsânie, Teodora Alexa-Stratulat, Bogdan Gafton, Eliza-Maria Froicu, Daniel Sur, Cristian Virgil Lungulescu, Natalia Gherasim-Morogai, Irina Afrăsânie, Lucian Miron, Mihai-Vasile Marinca
Publikováno v:
Cancers; Volume 15; Issue 4; Pages: 1265
We performed a retrospective study on 51 metastatic melanoma patients treated with Nivolumab in first line, at the Regional Institute of Oncology (RIO) Iasi, Romania between April 2017 and December 2019. We studied the efficacy and safety of anti-PD-
Autor:
Diana Cornelia Moisuc, Mihai Vasile Marinca, Andreea Mihaela Matei, Larisa Popovici, Petru Cianga
Publikováno v:
Healthcare
Volume 11
Issue 4
Pages: 591
Volume 11
Issue 4
Pages: 591
Health-related quality is of life of great importance in cancer care. This prospective study aimed to evaluate the impact of chemotherapy and bevacizumab on the activities of daily living, cancer symptoms, and general well-being in 59 metastatic colo
Autor:
Diana Cornelia Moisuc, Mihai Vasile Marinca, Bogdan Gafton, Teodora Alexa-Stratulat, Petru Cianga
Background: Treatment with bevacizumab is known to cause adverse effects such as proteinuria, hypertension, fistulas which, in addition to chemotherapy-induced toxicity, affect the quality of life. However, while bevacizumab-induced hypertension has
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8185f3bf001928f0b6f0c46e9bf4f80e
https://doi.org/10.21203/rs.3.rs-629964/v1
https://doi.org/10.21203/rs.3.rs-629964/v1